Novozymes A/S (OTCMKTS:NVZMY) Shares Gap Up – Still a Buy?

Novozymes A/S (OTCMKTS:NVZMYGet Free Report)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $56.89, but opened at $59.69. Novozymes A/S shares last traded at $58.38, with a volume of 9,414 shares.

Novozymes A/S Stock Up 2.3%

The firm has a fifty day simple moving average of $59.32 and a 200-day simple moving average of $61.44. The company has a market capitalization of $24.45 billion, a P/E ratio of 42.13, a P/E/G ratio of 1.05 and a beta of 1.11. The company has a quick ratio of 1.00, a current ratio of 0.72 and a debt-to-equity ratio of 0.12.

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) last released its quarterly earnings data on Wednesday, February 25th. The biotechnology company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.79 by ($0.44). The business had revenue of $1.18 billion for the quarter, compared to the consensus estimate of $1.22 billion. Novozymes A/S had a net margin of 13.96% and a return on equity of 6.37%. On average, equities research analysts expect that Novozymes A/S will post 1.82 EPS for the current fiscal year.

About Novozymes A/S

(Get Free Report)

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

Read More

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.